In an elderly patient who received a sodium‑phosphate enema and developed delirium four days ago, now presenting with increased anxiety, what urgent evaluation and management steps are recommended?

Urgent Evaluation for Sodium Phosphate Toxicity and Immediate Management

This elderly patient with persistent delirium 4 days after sodium phosphate enema administration and now worsening anxiety requires immediate laboratory evaluation for life-threatening electrolyte disturbances, particularly hyperphosphatemia and hypocalcemia, which can be fatal.

Critical Immediate Actions

1. Emergency Laboratory Assessment

Draw stat labs to evaluate for sodium phosphate toxicity 1, 2:

• Serum phosphorus (expect severe elevation: 5.3-45.0 mg/dL range reported)
• Ionized calcium (expect severe hypocalcemia: 2.0-8.7 mg/dL range)
• Serum sodium (hypernatremia common)
• Serum potassium (hypokalemia frequent)
• Renal function (BUN/creatinine - acute kidney injury present in all reported cases)
• ECG (for QT prolongation from hypocalcemia)

The timing is critical—most patients present within 24 hours, but complications can persist for days 2. Mortality reaches 45% in reported case series, making this a medical emergency 2.

2. Assess for Reversible Causes of Worsening Delirium

While awaiting labs, immediately evaluate 3:

• Hypoxia (pulse oximetry, consider ABG)
• Urinary retention (bladder scan)
• Constipation (abdominal exam, consider imaging if obstruction suspected)
• Volume status (hypotension and volume depletion are hallmark presentations) 2

3. Implement Non-Pharmacologic Delirium Management

Start immediately 3:

• Reorientation: Repeatedly explain where she is, who you are, your role
• Environmental modification: Ensure adequate lighting, minimize noise
• Communication: Explain situation to caregivers and how they can help
• Mobilization: Early mobilization if medically stable
• Sleep hygiene: Reduce nighttime interruptions

Pharmacologic Management of Anxiety in Context of Delirium

For the anxiety component specifically, use lorazepam 0.25-0.5 mg orally as needed (maximum 2 mg in 24 hours) given her elderly status 3. This lower dose is critical in elderly patients.

Important caveat: If she has ongoing delirium with agitation, consider haloperidol 0.5-1 mg orally at night and every 2 hours as needed (maximum 5 mg daily in elderly) 3. If both delirium and anxiety persist despite haloperidol, add lorazepam as above 3.

Do NOT use antipsychotics for anxiety alone—reserve them specifically for delirium management 4.

If Electrolyte Abnormalities Confirmed

Severe Hyperphosphatemia/Hypocalcemia Management:

• Immediate IV calcium replacement for symptomatic hypocalcemia (tetany, seizures, cardiac arrhythmias)
• Aggressive IV hydration with normal saline
• Consider urgent hemodialysis if phosphorus >10 mg/dL or refractory hypocalcemia 2, 5
• Discontinue any phosphate-containing products
• Monitor calcium-phosphate product (risk of tissue deposition) 2

Renal Function Support:

All patients in reported series developed acute renal failure 2. Nephrology consultation is warranted if creatinine elevated or rising.

Critical Pitfalls to Avoid

1. Missing the diagnosis: Sodium phosphate toxicity is frequently overlooked because symptoms (confusion, anxiety, agitation) are attributed solely to delirium rather than metabolic emergency 2, 5

2. Delayed recognition: The 4-day timeline suggests either delayed absorption, ongoing toxicity, or complications like acute kidney injury perpetuating electrolyte disturbances 2

3. Over-sedation: Elderly patients are exquisitely sensitive to benzodiazepines—always start with lowest doses 3

4. Using antipsychotics for anxiety: Antipsychotics are for delirium management, not anxiety alone, and carry risks in elderly patients 4

5. Assuming delirium will resolve without treating underlying cause: Persistent delirium beyond 4 days in this context strongly suggests ongoing metabolic derangement 6

Monitoring and Follow-up

• Serial electrolytes every 4-6 hours until stable
• Continuous cardiac monitoring if hypocalcemia confirmed
• Daily renal function assessment
• Delirium severity scoring (CAM-S or similar) to track response 4
• Fluid balance monitoring

Prognosis and Expectations

Even with treatment, delirium may persist for weeks to months in vulnerable elderly patients 7, 6. The worsening anxiety at day 4 suggests either progression of metabolic disturbance or evolution of delirium subtype. Recovery depends on correcting the underlying electrolyte abnormalities and preventing secondary complications like aspiration or falls.

The key message: This is not simple delirium—this is a potential sodium phosphate toxicity emergency requiring immediate laboratory confirmation and aggressive metabolic correction 2, 5.